The novel therapy of this peptide represents a major advance in the handling of diabetes mellitus type 2. Different to existing medications, tirzepatide targets two pathways – GLP-1 and GIP – providing improved https://tirzepatidepeptide193692.tribunablog.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-56734080